{"disease":{"id":"2019-novel-coronavirus-disease","name":"2019 novel coronavirus disease"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05615792","title":"Observational Cohort of COVID-19 Patients in Hubei Province","phase":"","overall_status":"COMPLETED","enrollment_count":68000,"lead_sponsor_name":"Dao Wen Wang","has_results":false},{"nct_id":"NCT05569408","title":"eVusheld Assessment reaL wORld Effectiveness in DoD Health System","phase":"","overall_status":"COMPLETED","enrollment_count":4724,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT05364268","title":"Evaluation of the AudibleHealth Dx AI/ML-Based Dx SaMD Using FCV-SDS in the Diagnosis of COVID-19 Illness: Clinical Validation","phase":"","overall_status":"COMPLETED","enrollment_count":514,"lead_sponsor_name":"AudibleHealth AI, Inc.","has_results":false},{"nct_id":"NCT05077332","title":"LEAP-CT for Treatment of COVID-19 Patients (Master Protocol)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":4,"lead_sponsor_name":"Leidos Life Sciences","has_results":false},{"nct_id":"NCT05077969","title":"Leidos-Enabled Adaptive Protocol (LEAP-CT) for Evaluation of Post-exposure Prophylaxis for Newly-infected COVID-19 Patients","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":4,"lead_sponsor_name":"Leidos Life Sciences","has_results":true},{"nct_id":"NCT05085574","title":"Leidos-Enabled Adaptive Protocol for Clinical Trials (LEAP-CT) in Hospitalized Patients With COVID-19 (Addendum 1)","phase":"PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Leidos Life Sciences","has_results":false}],"total":6},"guidelines":[],"source":"Drug Landscape verified database"}